EUVIMEDEUVIMED entdecken
Crossref

COMPARATIVE EFFECTIVENESS OF CONTEMPORARY WEIGHT-LOSS INJECTIONS AND ESTABLISHED BARIATRIC PROCEDURES

Dvir Levin

International Journal of Advanced Research · 30.04.2026 · 14 (04) · 550-558

DOI: 10.21474/ijar01/23223 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Advanced Research, online erschienen am 30.04.2026. Verfasst von Dvir Levin.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity management has shifted from a traditional lifestyle-versus-surgery framework to a broader continuum that now includes highly effective injectable anti-obesity medications. This revised narrative review compares established injectable therapies used in contemporary obesity care - liraglutide 3.0 mg, semaglutide 2.4 mg, and tirzepatide 5-15 mg - with major bariatric procedures, especially sleeve gastrectomy, Roux-en-Y gastric bypass, and selected duodenal switch procedures. In response to reviewer guidance, the methodology has been strengthened by adding a transparent literature-search strategy, explicit inclusion and exclusion criteria, a non-meta-analytic synthesis rationale, a formal ethical-clearance statement, and a critical-appraisal table of the principal evidence base. Across pivotal trials, mean total body-weight reduction was approximately 7.4% for liraglutide at 56 weeks, 14.9% for semaglutide at 68 weeks, and 20.9% for tirzepatide 15 mg at 72 weeks. In randomized or comparative bariatric literature, 5-year total weight loss was about 22.5% after sleeve gastrectomy and 26.0% after Roux-en-Y gastric bypass, while duodenal switch can exceed these results in selected high-BMI populations. Because medication and surgical estimates come from different trial designs, populations, follow-up durations, and outcome definitions, all comparisons are interpreted as indirect clinical benchmarks rather than exact head-to-head treatment effects. The main conclusion is that metabolic/bariatric surgery remains the most durable intervention for severe obesity, but modern injections have narrowed the efficacy gap and expanded individualized treatment options.

Zitieren

APA

Levin, D. (2026). COMPARATIVE EFFECTIVENESS OF CONTEMPORARY WEIGHT-LOSS INJECTIONS AND ESTABLISHED BARIATRIC PROCEDURES. International Journal of Advanced Research, 14(04), 550-558. https://doi.org/10.21474/ijar01/23223

Vancouver

Levin D. COMPARATIVE EFFECTIVENESS OF CONTEMPORARY WEIGHT-LOSS INJECTIONS AND ESTABLISHED BARIATRIC PROCEDURES. International Journal of Advanced Research. 2026;14(04):550-558. doi:10.21474/ijar01/23223

BibTeX
@article{Levin2026,
  author = {Levin, Dvir},
  title = {COMPARATIVE EFFECTIVENESS OF CONTEMPORARY WEIGHT-LOSS INJECTIONS AND ESTABLISHED BARIATRIC PROCEDURES},
  journal = {International Journal of Advanced Research},
  year = {2026},
  volume = {14},
  number = {04},
  pages = {550--558},
  doi = {10.21474/ijar01/23223}
}
Kostenlos starten →